Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-22Clinical Trial Update: An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) [Phase 2]
This open, single-center Phase 2 trial evaluates the safety and efficacy of Conbercept in patients with very low vision due to wet age-relat…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination [Phase 2]
This document reports a Phase 2 study update for AL-39324 in wet age-related macular degeneration, and notes that the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) [NA]
A completed clinical trial evaluated 0.5 mg intraocular ranibizumab (Lucentis) for diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Geographic Atrophy Treatment Evaluation [Phase 3]
A Phase 3 trial evaluating a treatment for geographic atrophy associated with age-related macular degeneration conducted by Alcon was termin…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD [Phase 3]
A Phase 3 trial comparing Anecortave Acetate to Visudyne for wet age-related macular degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I [Phase 1]
Phase I clinical trial of Ziv-aflibercept for retinal diseases, including age-related macular degeneration and central retinal vein occlusio…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration [Phase 3]
This is a Phase 3 clinical trial completion update for ranibizumab (rhuFab V2) in patients with minimally classic or occult subfoveal neovas…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Sirolimus for Advanced Age-Related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated sirolimus for advanced age-related macular degeneration and geographic atrophy; results were posted aft…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration [Phase 1]
The update reports the completion of a Phase 1 safety study of a topical treatment for dry age-related macular degeneration. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival [NA]
A completed trial compared topical versus subconjunctival anesthesia for intravitreal injections in AMD, CRVO, and DME. Results were posted …
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot [Phase 2]
This entry notes the completion of a Phase 2 pilot trial evaluating fluocinolone acetonide (Medidur) for age-related macular degeneration, w…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab [Phase 4]
Phase 4 clinical trial assessing indocyanine green angiography changes in choroidal neovascularization during ranibizumab treatment for exud…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 extension study of ranibizumab (rhuFab V2) for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Phase 3]
A Phase 3 clinical trial comparing rhuFab V2 to Verteporfin photodynamic therapy for subfoveal neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration. [Phase 2]
Phase 2 safety study on retinal transplantation for dry age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy [Phase 2]
Phase 2 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of ACU-4429 in geographic atrophy due to dry age-re…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating ranibizumab for choroidal neovascularization secondary to age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration [Phase 4]
This Phase 4 pilot trial compares ranibizumab with and without ketorolac eye drops for exudative age-related macular degeneration. The study…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) [Phase 2]
A multicenter Phase 2 proof-of-concept trial of intravitreal AL-78898A in geographic atrophy due to age-related macular degeneration was ter…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Genetic Load and Phenotype in Aggressive AMD
A completed clinical trial update examining genetic load and phenotype in aggressive age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Antioxidant Systems and Age-Related Macular Degeneration
This entry reports the completion of a clinical trial evaluating antioxidant systems in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Preventing Depression in Patients With Macular Degeneration [Phase 3]
Phase 3 trial evaluating prevention of depression in patients with macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration [Phase 2]
Phase 2 trial update evaluating E10030 (Anti-PDGF pegylated aptamer) plus Lucentis for neovascular age-related macular degeneration has comp…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Age-Related Eye Disease Study 2 (AREDS2) [Phase 3]
AREDS2 is a Phase 3 trial that has completed. It evaluated antioxidant and mineral supplementation for age-related macular degeneration and …
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration [Phase 1, Phase 2]
This document reports a Phase 1/2 safety study examining autologous bone marrow-derived stem cells as a treatment for age-related macular de…